糖尿病控制与并发症试验/糖尿病干预与并发症流行病学研究中参与者的足部溃疡和下肢截肢风险
在1型糖尿病患者中,DCCT研究平均6.5年的强化与常规血糖控制相比,在随后EDIC研究23年随访中,强化治疗与所有糖尿病足溃疡风险显著降低相关(HR 0.77,95%CI 0.60-0.97),首次记录的足部溃疡和首次下肢截肢风险降低幅度相似但未达统计学显著。
要点
- 强化血糖控制与所有糖尿病足溃疡风险显著降低相关(HR 0.77,95%CI 0.60-0.97)。
- 强化血糖控制对首次记录的足部溃疡和首次下肢截肢风险降低幅度相似但未达统计学显著。
- 临床神经病变、腓肠神经传导速度降低和心血管自主神经病变与足部溃疡风险升高相关。
核心结论
- 早期强化血糖控制可降低长期糖尿病足溃疡风险,而足部溃疡是下肢截肢因果路径中最重要的前驱事件。
研究设计与样本
- DCCT参与者在平均6.5年的强化或常规糖尿病治疗后,其中1,408例进入EDIC研究,每年通过体格检查随访足部溃疡和下肢截肢发生情况,随访23年。
- 采用多变量Cox比例风险回归模型估计DCCT治疗分组和时间更新暴露与足部溃疡或下肢截肢的关联。
主要发现
- 强化与常规血糖控制相比,所有糖尿病足溃疡风险显著降低(HR 0.77,95%CI 0.60-0.97)。
- 强化与常规血糖控制相比,首次记录的糖尿病足溃疡风险降低幅度相似但未达统计学显著(HR 0.78,95%CI 0.59-1.03)。
- 强化与常规血糖控制相比,首次下肢截肢风险降低幅度相似但未达统计学显著(HR 0.70,95%CI 0.36-1.36)。
- 在校正Cox模型中,临床神经病变、较低的腓肠神经传导速度和心血管自主神经病变与足部溃疡风险升高相关(P < 0.05)。
- 估计肾小球滤过率<60 mL/min/1.73 m2、白蛋白尿和黄斑水肿与下肢截肢风险升高相关;任何视网膜病变和较大的时间加权平均DCCT/EDIC HbA1c与两种结局风险升高相关(P < 0.05)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Intensive glycemic control reduces the risk of kidney, retinal, and neurologic complications in type 1 diabetes (T1D), but whether it reduces the risk of lower-extremity complications is unknown. We examined whether former intensive versus conventional glycemic control among Diabetes Control and Complications Trial (DCCT) participants with T1D reduced the long-term risk of diabetic foot ulcers (DFUs) and lower-extremity amputations (LEAs) in the subsequent Epidemiology of Diabetes Interventions and Complications (EDIC) study. RESEARCH DESIGN AND METHODS: DCCT participants (n = 1,441) completed 6.5 years on average of intensive versus conventional diabetes treatment, after which 1,408 were enrolled in EDIC and followed annually over 23 years for DFU and LEA occurrences by physical examination. Multivariable Cox proportional hazard regression models estimated associations of DCCT treatment assignment and time-updated exposures with DFU or LEA. RESULTS: Intensive versus conventional glycemic control was associated with a significant risk reduction for all DFUs (hazard ratio 0.77 [95% CI 0.60, 0.97]) and a similar magnitude but nonsignificant risk reduction for first-recorded DFUs (0.78 [0.59, 1.03]) and first LEAs (0.70 [0.36, 1.36]). In adjusted Cox models, clinical neuropathy, lower sural nerve conduction velocity, and cardiovascular autonomic neuropathy were associated with higher DFU risk; estimated glomerular filtration rate <60 mL/min/1.73 m2, albuminuria, and macular edema with higher LEA risk; and any retinopathy and greater time-weighted mean DCCT/EDIC HbA1c with higher risk of both outcomes (P < 0.05). CONCLUSIONS: Early intensive glycemic control decreases long-term DFU risk, the most important antecedent in the causal pathway to LEA.
引用
- Boyko EJ, Zelnick LR, Braffett BH, et al. Risk of Foot Ulcer and Lower-Extremity Amputation Among Participants in the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Study. Diabetes Care. 2022. PMID: 35007329. doi:10.2337/dc21-1816
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。